Safety, Tolerability and Clinical Effects of a Rapid Dose Titration of Subcutaneous Treprostinil Therapy in Pulmonary Arterial Hypertension: A Prospective Multi-Centre Trial

Ekkehard Grünig,Nicola Benjamin,Tobias Lange,Ulrich Krueger,Hans Klose,Claus Neurohr,Heinrike Wilkens,Michael Halank,Hans-Juergen Seyfarth,Matthias Held,Andrew Traube,Michelle Pernow,E. Robert Grover,Benjamin Egenlauf,Felix Gerhardt,Thomas Viethen,Stephan Rosenkranz

Safety, Tolerability and Clinical Effects of a Rapid Dose Titration of Subcutaneous Treprostinil Therapy in Pulmonary Arterial Hypertension: A Prospective Multi-Centre Trial

2016

Ekkehard Grünig
Nicola Benjamin
Tobias Lange
Ulrich Krueger
Hans Klose
Claus Neurohr
Heinrike Wilkens
Michael Halank
Hans-Juergen Seyfarth
Matthias Held
Andrew Traube
Michelle Pernow
E. Robert Grover
Benjamin Egenlauf
Felix Gerhardt
Thomas Viethen
Stephan Rosenkranz

Background: Subcutaneous treprostinil has dose-dependent beneficial effects in patients with severe pulmonary arterial hypertension, but adverse effects like infu

Keywords:

Treprostinil
Anesthesia
Intensive care medicine
Adverse effect
Diabetes mellitus
Tolerability
Medicine
in patient
dose titration
safety tolerability
multi centre
beneficial effects

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations